1. Introduction {#sec1}
===============

Obesity is well-recognised as a disease process leading to multiple pathological consequences. The WHO declared obesity to be an epidemic in 1998 \[[@B1]\]. In countries where data are available, prevalence rates of obesity today are about four times those of thirty years ago \[[@B1], [@B2]\]. Unfortunately, most strategies to reduce or even curb increases in rates of obesity have been largely unsuccessful \[[@B3]--[@B6]\]. Our so-called obesogenic environment has been blamed for the dramatic increase in obesity rates in recent years, as genetics alone cannot account for such dramatic changes in a relatively short time-frame.

Some obesity experts have made dire predictions for future obesity prevalence rates. For instance, Wang et al. \[[@B7]\] have predicted that by the year 2048, all American adults would become overweight or obese. However, evidence suggests that these predictions may be flawed. Information from cross-sectional and prospective studies on temporal changes in body mass index (BMI) indicate that the population distribution of BMI is positively skewed and that over time the degree of skew has increased \[[@B8]--[@B13]\]. This means that there is proportionally more shifting at the upper end of the distribution curve with the lower end of the distribution remaining relatively static. That is, within a population, more people are becoming overweight and obese; however, there still remains a substantial sector of the population who have remained lean, seemingly resistant to this obesogenic environment.

Most obesity researchers have investigated the characteristics of overweight and obese individuals and populations in an attempt to determine the cause, treatment, and prevention of obesity. An alternative approach is to study those who have remained lean despite living in an obesogenic environment. Information from this group may allow us to develop novel strategies to benefit those who continually struggle to maintain a healthy body weight.

One potential difference between those who struggle with their weight and those who remain lean with seeming ease may involve appetite regulation. Several hormones have important roles in regulating appetite. For example, ghrelin, an orexigenic peptide, appears important in meal initiation \[[@B14]\], whereas PYY may reduce food intake \[[@B15]\]. A previous study compared concentrations of ghrelin, PYY, glucagon-like peptide 1 (GLP-1), and leptin measured every 4 h over a 24 h period among those considered constitutionally thin (CT) and a group of healthy weight individuals \[[@B16]\]. Individuals were considered CT if they met the following criteria: a BMI between 14.5 and 16.5 kg·m^−2^, stable weight throughout the postpubertal period, presence of menstrual periods without estroprogestative treatment, and the desire to gain weight. Ghrelin, GLP-1, and leptin concentrations were significantly lower, while PYY was significantly higher in the CT group compared to normal weight controls. One could propose that the hormone profile of CT individuals may protect them from overeating and therefore in part explain how thin individuals remain lean despite living in an obesogenic environment. However, it is equally likely that potential differences in eating patterns between the CT and normal weight controls result in changes in the hormone profile.

Some \[[@B17]--[@B19]\], but not all \[[@B20]\] research has reported lower baseline and postprandial ghrelin concentrations in obese individuals when compared to their lean counterparts. The suppression of ghrelin in response to a meal may indicate some form of dysregulation of appetite hormones in obese individuals. In addition, ghrelin levels increase with subsequent weight loss, implying a role in long-term weight regulation. It has also been suggested that lower fasting ghrelin may be a consequence of downregulation caused by overeating \[[@B21]\]. Two anorexigenic hormones, Peptide YY and GLP-1, are reported to be lower in obese individuals, suggesting differences in these hormones may be contributing to higher energy intakes in the obese \[[@B19], [@B22], [@B23]\].

It would therefore be of interest to compare the hormone profiles of those who report they remain lean with relative ease (ORI) with those who report they struggle to maintain a healthy body weight (OSI). As some studies have shown that ghrelin secretion mirrors reported hunger \[[@B14], [@B20], [@B24]\], it would also be worthwhile to investigate any differences in appetite indices between these two diverse groups of individuals.

We investigated hormone concentrations and appetite indices in response to a standard meal among those who remain lean with ease and those who constantly struggle with their weight.

2. Materials and Methods {#sec2}
========================

2.1. Subjects {#sec2.1}
-------------

Sixty-one participants were recruited from the general public in Dunedin, New Zealand, via the distribution of flyers, designed with specific questions to target obesity susceptible and obesity resistant individuals, around local supermarkets, advertising in the local newspaper, and emails sent to University staff.

To be eligible, participants were required to be healthy males or females aged between 20 and 45 years. Participants completed a screening questionnaire to see if they met our study criteria as either an obesity susceptible individual (OSI) (struggles to maintain their weight, despite perceived low energy intakes) or an obesity resistant individual (ORI) (remains lean with relative ease and can eat whatever they like). Participants were classified as OSI if they answered positively to either or both of the following two statements:*I am a person who needs to eat small amounts of food to manage my weight,I am a person who gains weight easily.*

Conversely, participants were classified as ORI if they answered positively to any of the following statements:*I am a person who can eat whatever I like without gaining weight,I am a person who maintains my weight easily,I am a person who loses weight easily,I am a person who finds it difficult to put on weight.*

Participants were excluded if they did not answer positively to any of the screening tool questions, had a thyroid disorder, or were menopausal. In total 28 OSI and 33 ORI were recruited. Obesity resistant individuals had a BMI of 17.5--27.7 kg/m^2^, had always been lean (as indicated by self-reported weight history), and found it difficult to gain but not lose weight. In contrast, OSI had a BMI of 21.6--44.0 kg/m^2^, were likely to experience fluctuations in weight (as indicated by self-reported weight history), and found it difficult to lose but not gain weight. The study protocol was approved by the Human Ethics Committee of the University of Otago, New Zealand. All participants provided written informed consent.

2.2. Experimental Design and Procedures {#sec2.2}
---------------------------------------

Each participant attended a 4 h clinic visit at the Department of Human Nutrition, University of Otago. Participants arrived at the clinic after an overnight fast of at least 10 h. A fasting fingerprick blood sample using a disposable lancet was taken for measurement of ghrelin (active), PYY (total), leptin, glucose, and insulin. Capillary blood samples were collected in microcentrifuge tubes containing potassium EDTA. This was followed by the consumption of a standardised meal that participants were asked to consume within 15 min. Further capillary blood samples were collected at 15, 30, 60, 120, and 180 min following the start of ingestion of the meal. Participants also completed an appetite questionnaire at each blood sampling time-point.

2.3. Standardized Meal {#sec2.3}
----------------------

The standardized meal was designed to provide 2440 kJ (584 kcal) for females and 2928 kJ (700 kcal) for males made up of 55, 29, and 15 percent of the total energy intake from carbohydrate, fat, and protein, respectively.The meal was comprised of a muesli cereal (containing oats, wheat germ, Special K (Kelloggs), brown sugar, desiccated coconut, skimmed milk powder, full fat milk, canola oil, almonds, sultanas, dried apricots, sunflower seeds), milk, yoghurt, and orange juice. Participants were required to consume the entire standardized meal. Because the response of important study variables (namely, ghrelin, PYY, and appetite scores) has been shown to be proportional to caloric intake and because this study was cross-sectional, we decided to fix caloric intake for each sex to reduce interindividual variability.

2.4. Sampling and Biochemical Analysis {#sec2.4}
--------------------------------------

Capillary blood samples (1 mL) were collected in 1.5 mL microcentrifuge tubes containing 10 *μ*L of sodium EDTA. Immediately prior to blood collection, 10 *μ*L of serine protease inhibitor was added for the ghrelin (active) measurement. Upon blood collection the tubes were gently inverted and stored on ice. Samples were then centrifuged for 15 min to obtain plasma, which was stored in microcentrifuge tubes at −80°C until assay. Whole capillary blood was also collected into a HemoCue cuvette and blood glucose concentration measured using a HemoCue Glucose 201+ Analyzer (Helsingborg, Sweden).

Ghrelin (active), PYY (total), leptin, and insulin were analysed using immunoassay (Human Gut Hormone Panel LINCOplex Kit, LINCO Research, St. Charles, MO, USA). The minimum detectable concentrations for the hormones were 1.8 pg·mL^−1^ for ghrelin (active), 8.4 pg·mL^−1^ for PYY (total), 157.2 pg·mL^−1^ for leptin, and 44.5 pg·mL^−1^ for insulin. The coefficient of variation for measurements of ghrelin, PYY (total), leptin, and insulin was 13.0%, 8.1%, 11.8%, and 8.4% respectively.

Area under the curve (AUC) for ghrelin, PYY (total), leptin, glucose, and insulin was calculated by the trapezoid method.

2.5. Appetite Ratings {#sec2.5}
---------------------

At each blood sampling time-point participants completed a series of appetite related questions using a 10 cm visual analogue scale (VAS) \[[@B25], [@B26]\]. In relation to each question, there were extreme states anchored at either end of the line. The questions asked were "how hungry are you right now?" (not at all hungry/as hungry as I\'ve ever felt); "preoccupation with thoughts of food" (no thoughts of food/very preoccupied, difficult to concentrate); "how strong is your desire to eat right now" (very weak/very strong); and "how full are you right now?" (not at all full/as full as I have ever felt). The VAS was measured by an investigator blinded to the study group. Area under the curve (AUC) for each rating was calculated by the trapezoid method. The observed peak/nadir and time to peak/nadir were recorded. The three-factor eating questionnaire (TFEQ) \[[@B27]\] was administered on a separate occasion before the 4 h clinic visit.

2.6. Body Composition {#sec2.6}
---------------------

Body weight was measured on calibrated electronic scales (Wedderburn) that measured to the nearest 0.01 kg. Height was measured to the nearest millimeter using a stadiometer. Body composition including lean mass, fat mass, and body fat percentage (%BF) was measured using dual-energy X-ray absorptiometry (DXA) (manufacturer info DPX-L Scanner, Lunar Corp., Cincinnati, OH, USA) using software version 1.35 (Lunar, Cincinnati, OH, USA) at the Dunedin Public Hospital Dual X-Ray Absorptiometry Scanning Unit. Following screening, participants also completed a questionnaire regarding past-weight history. Weight history information was not used to further categorise the participants, but it did confirm their status as obesity resistant or obesity susceptible. When entering the study participants self-reported being weight stable.

2.7. Statistical Analysis {#sec2.7}
-------------------------

The primary outcome measure to be assessed was the postprandial change in ghrelin. Thirty participants per group (OSI and ORI) were required to detect a difference of 5% in the serial measurements of ghrelin with a power of 90% and alpha 0.05. Participant characteristics are presented as arithmetic means and standard deviations (SD). The results show the differences for sex adjusted for obesity resistance/susceptibility category (ORS) and differences for ORS adjusted for sex from regression analysis. A further adjustment %BF was conducted by including a term for %BF in the regression model. An interaction between sex and ORS group was considered but as it was not statistically significant it was not included in the final model. The fasting and AUC hormone variables were log transformed before analysis. The results are presented as medians (interquartile range). No adjustment was made for multiple testing. Statistical analysis was performed using STATA Version 12 (STATA Inc., College Station, TX).

3. Results {#sec3}
==========

3.1. Participant Characteristics {#sec3.1}
--------------------------------

The characteristics of study participants are shown in [Table 1](#tab1){ref-type="table"}.

3.2. Hormone Analyses {#sec3.2}
---------------------

Fasting, AUC, peak or nadir, and time to peak or nadir results for ghrelin, PYY (total), leptin, glucose, and insulin adjusted for ORS and sex with and without adjustment for %BF are presented in [Table 2](#tab2){ref-type="table"}.

3.3. Ghrelin and PYY {#sec3.3}
--------------------

No differences related to ORS or sex were observed in the analysis of ghrelin or PYY.

3.4. Leptin {#sec3.4}
-----------

Fasting leptin concentration and leptin AUC were significantly greater in females compared to males. The nadir for leptin was also higher in females compared with males. However, these differences disappeared when controlling for %BF. Fasting leptin concentration, leptin AUC, and nadir for leptin were all lower in ORI compared with OSI. Again, these differences disappeared when controlling for %BF. No differences were observed in the leptin time to nadir.

3.5. Glucose and Insulin {#sec3.5}
------------------------

There were no significant differences for fasting, AUC, or time to peak for blood glucose for OSI versus ORI or males versus females. Peak blood glucose was significantly higher in males compared to females. Fasting insulin and insulin AUC were significantly lower in ORI compared with OSI. These differences disappeared when controlling for %BF.

3.6. Subjective Ratings of Hunger and Satiety {#sec3.6}
---------------------------------------------

Fasting, AUC, peak or nadir, and time to peak or nadir results for "hunger," "desire to eat," "fullness," and "preoccupation with thoughts of food" adjusted for ORS and sex with and without adjustment for %BF are presented in [Table 3](#tab3){ref-type="table"}.

The nadir for "hunger" was significantly lower for OSI compared with ORI. The fasting rating of "preoccupation with thoughts of food" was significantly higher in females compared with males. Differences were also observed in the time to nadir for the "preoccupation with thoughts of food" rating, with the nadir occurring significantly later in ORI versus OSI. These differences disappeared after controlling for %BF. There were no significant differences observed in fasting, AUC, peak, or time to peak for ratings of "fullness" or "desire to eat."

3.7. Three-Factor Eating Questionnaire (TFEQ) {#sec3.7}
---------------------------------------------

The TFEQ results are presented in [Table 3](#tab3){ref-type="table"} and [Figure 1](#fig1){ref-type="fig"}. Dietary restraint scores were significantly lower in ORI versus OSI (*P* \< 0.001). Disinhibition scores were significantly lower in ORI versus OSI (*P* \< 0.001), while no significant differences were observed in scores for hunger. These differences remained statistically significant after adjustment for %BF.

4. Discussion {#sec4}
=============

Why some individuals remain lean with relative ease while others constantly struggle with their body weight, despite living in a similar environment, is an intriguing question. Although the majority of research in the obesity field has focused on the characteristics of obese individuals, an alternative approach is to compare the characteristics of those who are seemingly resistant to obesity (ORI) with those who appear highly susceptible (OSI). One reason for the difference in weight gain susceptibility may be due to physiological differences in appetite control. We studied the hormonal response to a standardized meal amongst ORI and OSI. Despite some differences in absolute values of these hormones, the patterns of change in response to a standard meal were remarkably similar between ORI and OSI.

As expected, ghrelin concentrations decreased in all groups upon feeding reaching a nadir between 30 and 60 min. Ghrelin, an orexigenic hormone, is acutely negatively regulated by the ingestion of meals and positively regulated by fluxes in overall energy balance \[[@B14]\]. Most previous studies have shown that total ghrelin is negatively correlated with %BF (obese individuals tend to have lower fasting ghrelin levels compared to lean controls) \[[@B17]--[@B19]\]. Based on these previous observations, one might have anticipated ORI (%BF: 23.4 in females, 15.4 in males) to have a higher fasting ghrelin compared to OSI (%BF: 41.9 in females, 27.6 in males). However, our study showed no differences in ghrelin concentration between ORI and OSI. Perhaps this is evidence that ORI and OSI respond differently, in terms of eating behaviour, to the same ghrelin concentration. That is, the OSI\'s higher level of dietary restraint and disinhibition may indicate that they are either more responsive to orexigenic signals and/or less responsive to anorectic factors.

Similar gherlin concentrations, despite different body composition and therefore energy stores, have also been observed in the study cohorts of two previous studies. Khoury et al. \[[@B28]\] compared gut hormone response to three standardized meals in a group with the metabolic syndrome and lean controls. Despite a 15% difference in mean body fat (33.5% versus 17.9%) there was no difference in active ghrelin. Mittelman et al. \[[@B19]\] showed that although fasting active ghrelin concentration was lower in obese, postprandial increases were similar in both lean and obese children.

The similarities in ghrelin concentration among the two groups may reflect two different mechanisms. Whereas the OSI ghrelin levels are due to increased energy stores, the ORI may have lower than predicted ghrelin levels due to a possible underlying protective mechanism which theoretically could protect against overeating and subsequent weight gain. Thus, no obvious difference between the two groups is apparent. Obesity resistance individuals may differ from other populations previously studied in that they largely struggle to gain weight rather than simply being lean. One previous study that investigated constitutionally thin (i.e., those who find it difficult to gain weight) also found lower ghrelin levels than expected given their low %BF \[[@B16]\]. As ghrelin is orexigenic this finding may indicate a possible mechanism that prevents these particularly lean individuals from overeating.

PYY is an anorexigenic hormone that has been associated with meal satiety and thus theoretically meal termination \[[@B15]\]. One may expect that those who remain lean with relative ease have a higher concentration of these hormones in response to feeding when compared to those who struggle to maintain a healthy body weight. In the majority of previous studies investigating overweight and/or obese compared to lean subjects, PYY levels were higher amongst lean individuals postprandially, suggesting a blunted response in overweight/obese individuals \[[@B16], [@B19], [@B20], [@B22], [@B24]\]. In contrast, we found no difference in PYY concentrations in response to a meal. This finding compliments the ghrelin results and may also indicate a differential response to the same PYY level in ORI versus OSI. Khoury et al. \[[@B28]\] also observed no differences in PYY responses and AUC between individuals with the metabolic syndrome and controls in response to a variety of meals.

Consistent with results from previous studies where higher leptin concentrations have been associated with increases in BMI \[[@B17], [@B29]\], the fasting and postprandial leptin concentrations in the present study were also higher in the group with greater BMI (OSI). This is in line with previous literature that has highlighted the concept of leptin resistance in overweight and obese individuals as a result of increased adipose tissue stores \[[@B30]\]. In our study OSI have markedly higher leptin concentrations than ORI but equivalent satiety scores. This suggests that OSI are not responding fully to the high concentrations of leptin.

In the face of similar hormone patterns it would have been of interest to observe how much our two groups would have eaten when presented with an*ad libitum* meal. Would they choose a similar meal size or would OSI have actually wanted to eat more? Future research should seek to investigate this as it represents a more realistic eating situation.

In addition to the potential differential response to the hormones in these two distinct groups of individuals there were some differences in perceived appetite ratings. Most notably, the ORI experienced smaller fluctuations in hunger ratings. In addition, the TFEQ indicates that ORI may respond differently to hunger in that they are less likely to engage in dietary restraint and disinhibition behaviours. This style of eating could be an artifact of the differential response to the hormones or may be in response to some psychological factors or learned behaviour. Overeating and lack of response to satiety cues may be a learned response that affects some to a greater extent than others. Physiological signals and behavioural cues both regulate appetite and energy intake. Which one predominates may depend on a number of factors including genetics, the environment, past experiences, parental influence, sensory stimulation, social situation, and psychological well-being.

There are some limitations that should be considered when interpreting the results of this study. Firstly, the cross-sectional design of the study does not allow us to draw casual inferences and the sample size was relatively small. Further, given that ghrelin plasma concentrations differ throughout the day in cyclic fashion in relation to meal taking and diurnal rhythms \[[@B14]\], it may be that the analyses simply did not capture ghrelin differences as values were only assessed over a 4 h period in the morning. In addition, any differences observed between males and females may be attributable to differences in the energy content of the standardized meal as this was based on sex rather than estimated energy requirements. This method for assigning energy content to the standardized meal could also potentially have resulted in the OSI eating less and the ORI eating more than they are used to. Furthermore, current dieting patterns may have influenced the results as individualswho were in a pattern of energy restriction may have responded differently compared to someone who was not actively trying to lose weight.

In conclusion, comparing people who remain lean despite living in an obesegenic environment (ORI) to those who struggle to maintain a healthy weight (OSI) has provided us with a novel approach to investigate the aetiology of obesity. Given the differential body weights observed in the two study groups in the present study, a similar ghrelin concentration was unexpected. This could indicate that OSI respond differently to the same ghrelin concentration. Conversely, the lower than expected fasting ghrelin levels observed in the ORI may provide a protective mechanism that enables these individuals to remain lean. This warrants further investigation. The higher levels of dietary restriction and disinhibition amongst OSI indicate that psychosocial factors are likely also important regulators of energy balance in this group.
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###### 

Characteristics of obesity resistant individuals (ORI) and obesity susceptible individuals (OSI).

                       ORI           OSI           *P* value\*                 
  -------------------- ------------- ------------- ------------- ------------- ---------
  *n*                  16            17            15            13             
  Age (years)          32.6 (7.6)    30.6 (7.7)    35.0 (7.7)    35.5 (9.1)    0.081
  Weight (kg)          56.3 (5.3)    73.3 (10.7)   86.6 (15.2)   94.1 (11.0)   \<0.001
  Height (m)           1.65 (0.06)   1.81 (0.08)   1.66 (0.05)   1.79 (0.04)   0.400
  WC (cm)              71.6 (6.0)    80.4 (4.7)    95.6 (10.8)   99.4 (11.7)   \<0.001
  BMI (kg/m^2^)        20.6 (1.8)    22.3 (2.9)    31.6 (6.2)    29.5 (3.3)    \<0.001
  LBM (kg)             40.1 (4.2)    58.5 (9.1)    45.8 (3.7)    63.7 (7.6)    0.002
  Fat Mass (kg)        13.1 (2.9)    11.3 (4.6)    37.2 (14.2)   26.1 (8.1)    \<0.001
  \% Body Fat          23.4 (4.8)    15.4 (5.6)    41.9 (9.9)    27.6 (7.1)    \<0.001
  TSH (*μ*IU·mL^−1^)   1.45 (0.96)   1.78 (0.97)   1.67 (0.77)   1.58 (0.82)   0.958

All values are means (standard deviation).

BMI: Body Mass Index, LBM: Lean Body Mass, TSH: Thyroid Stimulating Hormone (reference range = 0.3--5 *μ*IU·mL^−1^ for adults with no known thyroid dysfunction), WC: waist circumference.

\**P* value from regression analysis for ORS adjusted for sex.

###### 

Hormone profiles in obesity resistant individuals (ORI) and obesity susceptible individuals (OSI) in response to a standardised meal.

                          ORI   OSI      *P* value\*      *P* value^†^   *P* value^‡^                                                                                                                 
  ----------------------- ----- -------- ---------------- -------------- -------------- ---------------- ---- --------- ----------------- ---- -------- ----------------- ------------- ------------- -------
  Ghrelin                                                                                                                                                                                              
   Fasting (pg·mL^−1^)    14    70.7     39.2--129.5      17             55.2           38.6--137.3      12   69.3      59.5--105.5       12   55.0     35.6--65.1        0.319         0.600         0.662
   AUC (mmol·min^−1^)     11    12596    7470--16987      16             11341          8747--21848      9    11232     9252--14968       9    9889     6136--10693       0.857         0.460         0.751
   Nadir (pg·mL^−1^)      16    44.9     31.5--55.3       17             33.7           27.1--56.7       14   39.4      31.2--46.7        13   35.3     18.0--38.7        0.419         0.287         0.822
   Time to nadir (min)    16    60       30--60           17             60             60-60            14   30        30--60            13   60       60-60             0.058         0.518         0.580
  PYY                                                                                                                                                                                                  
   Fasting (pg·mL^−1^)    14    47.9     40.1--53.7       17             55             47.8--65.3       14   47.1      37.5--67.3        12   56.4     49.4--62.0        0.161         0.889         0.761
   AUC (mmol·min^−1^)     13    11700    10954--13230     16             12511          10524--13597     12   12779     10777--18752      9    12877    12436--13739      0.825         0.601         0.736
   Peak (pg·mL^−1^)       16    72.6     68.2--82.0       17             77.8           66.7--87.5       15   75.4      55.0--112.4       13   75.7     68.7--87.5        0.981         0.877         0.916
   Time to peak (min)     16    60       45--120          17             60             30--120          15   120       60--180           13   30       30-30             0.275         0.584         0.526
  Leptin                                                                                                                                                                                               
   Fasting (pg·mL^−1^)    16    2426     1367--3626       17             693.4          440.9--1495.0    15   14367     4135--24941       12   2480     1424--8725        **\<0.001**   **\<0.001**   0.324
   AUC (mmol·min^−1^)     16    425506   231672--582562   16             101878         74897--237294    14   1753714   502753--4671533   9    410572   268776--1746261   **\<0.001**   **\<0.001**   0.378
   Nadir (pg·mL^−1^)      16    2003     1184--2986       17             531.7          339.7--1313.4    15   9015      2661--24450       13   2108     1198--6836        **0.003**     **0.001**     0.946
   Time to nadir (min)    16    60       15--120          17             60             30--120          15   60        15--120           13   60       30--120           0.781         0.558         0.949
  Glucose                                                                                                                                                                                              
   Fasting (mmol·L^−1^)   16    5.30     5.00--5.53       17             5.25           4.95--5.40       15   5.25      5.05--5.30        13   5.25     5.05--5.50        0.851         0.900         0.887
   AUC (mmol·min^−1^)     16    1030     995--1063        17             1054           1013--1081       15   1062      970--1128         13   1048.0   992--1113         0.298         0.252         0.954
   Peak (mmol·L^−1^)      16    6.9      6.70--7.55       17             7.3            7.00--8.00       15   7.2       6.7--7.8          13   7.5      7.10--7.60        **0.038**     0.540         0.759
   Time to peak (min)     16    15       15--30           17             30             30-30            15   30        15--30            13   30       30-30             0.103         0.072         0.352
  Insulin                                                                                                                                                                                              
   Fasting (pg·mL^−1^)    13    157      131.1--177.1     15             236.7          110.3--299.6     14   252.2     187.0--355.5      11   398      281.3--466.5      0.085         **0.004**     0.213
   AUC (mmol·min^−1^)     12    105038   92640--143522    14             139943         108035--171234   12   175434    104685--217197    8    213250   131498--321104    0.057         **0.016**     0.802
   Peak (pg·mL^−1^)       16    1345.1   965.9--1867.8    17             1677.5         1250.4--2298.3   15   1467.9    1098.9--2294.6    13   1849     1453--2475        0.145         0.196         0.632
   Time to peak (min)     16    30       30-30            17             30             30-30            15   30        30-30             13   30       30-30             0.466         0.379         0.716

%BF: percent body fat, AUC: area under the curve, ORS: obesity resistance/susceptibility category.

Fasting and AUC data have been log transformed, \**P* value for sex adjusted for ORS, ^†^ *P* value for ORS adjusted for sex, ^‡^ *P* value for ORS adjusted for sex and %BF.

###### 

Appetite ratings for obesity resistant individuals (ORI) and obesity susceptible individuals (OSI) in response to a standardised meal.

                            ORI   OSI    *P* value\*   *P* value^†^   *P* value^‡^                                                                                             
  ------------------------- ----- ------ ------------- -------------- -------------- ------------- ---- ------- ------------ ---- ------ ----------- ----------- ------------- -------------
  Hunger                                                                                                                                                                        
   Fasting (mm)             16    73     55--86        17             67             49--84        15   65      51−77        13   60     40−70       0.515       0.074         0.341
   AUC (mm·min^−1^)         16    9049   4819--10084   17             6413           4200--10358   15   4275    2798−6780    13   6158   5528−9443   0.506       0.056         0.785
   Nadir (mm)               16    22     2--30         17             19             10--36        15   1       0−4          13   9      1−27        0.170       **0.017**     0.414
   Time to Nadir (min)      16    15     15--30        17             30             15--60        15   15      15−30        13   15     15−30       0.656       0.305         0.252
  Fullness                                                                                                                                                                      
   Fasting (mm)             15    13     5--20         17             16             6--28         15   14      3-41         13   17     1−28        0.871       0.918         0.826
   AUC (mm·min^−1^)         15    7095   6158--8670    17             6720           4800--10125   15   10185   6600−11295   13   7088   5595−7598   0.053       0.451         0.470
   Peak (mm)                16    76     64--95        17             71             49--77        15   90      74−96        13   63     51−77       0.817       0.482         0.754
   Time to peak (min)       16    15     15--30        17             15             15--30        15   15      15−30        13   30     15−30       0.380       0.119         0.860
  Preoccupation with Food                                                                                                                                                       
   Fasting (mm)             16    63     49--85        17             34             28--63        15   57      30−70        13   41     15−68       **0.015**   0.448         0.987
   AUC (mm·min^−1^)         16    6008   3173--8948    17             4628           2805--10830   15   2813    1875−7155    13   6660   2378−8663   0.496       0.294         0.455
   Nadir (mm)               16    15     4--31         17             10             4--27         15   1       0−8          13   15     1−25        0.309       0.193         0.871
   Time to Nadir (min)      15    15     15--30        17             30             15--30        15   15      15−30        13   15     15−60       0.092       **0.040**     0.888
  Desire to Eat                                                                                                                                                                 
   Fasting (mm)             16    76     58--85        17             64             45--85        15   69      49−79        13   61     35−72       0.336       0.199         0.243
   AUC (mm·min^−1^)         16    8456   4943--10609   17             6473           4118--10913   15   3900    2753−6938    13   6705   5723−9788   0.389       0.148         0.427
   Nadir (mm)               16    25     2--31         17             18             10--31        15   2       0−5          13   15     1−31        0.134       0.059         0.745
   Time to Nadir (min)      16    15     15--30        17             15             15--30        15   15      15−30        13   30     15−60       0.770       0.923         0.940
  TFEQ                                                                                                                                                                          
   Dietary Restraint        16    4      0--12         17             4              3--5          15   9       3−18         13   6      4−8         0.337       **\<0.001**   **\<0.001**
   Disinhibition            16    3      1--10         17             3              2--5          15   12      3−15         13   7      5−10        0.255       **\<0.001**   **0.005**
   Hunger                   16    8      1--13         17             8              3--9          15   6       1−13         13   8      4−10        0.791       0.749         0.665

%BF: percent body fat, AUC: area under the curve, ORS: obesity resistance/susceptibility category, TFEQ: three factor eating questionnaire.

\**P* value for sex adjusted for ORS, ^†^ *P* value for ORS adjusted for sex, ^‡^ *P* value for ORS adjusted for sex and %BF.

[^1]: Academic Editor: Joseph R. Vasselli
